IL4 and B-cell chronic lymphocytic leukemia: We then tested these drug combinations in the primary CLL cells, both in the native condition (Figure 7A) and in media supplemented with cytokines (CD40 ligand and interleukin-4) to mimic the microenvironment and maintain viability (Figure 7B).